(Total Views: 258)
Posted On: 10/13/2019 7:55:40 AM
Post# of 36566
Re: Paul Jackson #7127
Revenue...from the WSR interview in Jan:
"Generex Biotechnology Corp. (OTC: GNBT) Interview with CEO Joe Moscato. Joe shares an update on the continued transformation of Generex into a next-generation integrated pharmaceutical healthcare business, through strategic acquisitions. Generex’s recent acquisition of medical services assets is generating over $75 million in revenues and is expect to generate over $1 billion annual revenues, as it expands to multiple states over the next 18 months."
It wouldn't take a ton of those sized clinics to reach the target in revenue. We'll just have to see how many come on board. Lot's of smaller clinics out there that should be interested as the word gets out.
"Generex Biotechnology Corp. (OTC: GNBT) Interview with CEO Joe Moscato. Joe shares an update on the continued transformation of Generex into a next-generation integrated pharmaceutical healthcare business, through strategic acquisitions. Generex’s recent acquisition of medical services assets is generating over $75 million in revenues and is expect to generate over $1 billion annual revenues, as it expands to multiple states over the next 18 months."
It wouldn't take a ton of those sized clinics to reach the target in revenue. We'll just have to see how many come on board. Lot's of smaller clinics out there that should be interested as the word gets out.
(1)
(0)
